Solicitation of Nominations for Appointment to the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, 11543-11544 [2018-05278]
Download as PDF
<![CDATA[
11543
Federal Register / Vol. 83, No. 51 / Thursday, March 15, 2018 / Notices
TABLE 1—RECIPIENTS AND AWARD AMOUNTS—Continued
Grant number
H80CS00802
H80CS00436
H80CS00283
H80CS00291
H80CS06445
...................................
...................................
...................................
...................................
...................................
Harrington Family Health Center ..............................................................
Family Health Centers of Baltimore ..........................................................
Oakland Primary Health Services, Inc ......................................................
The University of Pittsburgh ......................................................................
Fourth Ward d.b.a. Good Neighbor Healthcare Center ............................
Matt
Kozar, Strategic Initiatives and Planning
Division Director, Office of Policy and
Program Development, Bureau of
Primary Health Care, Health Resources
and Services Administration, at
mkozar@hrsa.gov or 301–443–1034.
FOR FURTHER INFORMATION CONTACT:
Dated: March 8, 2018.
George Sigounas,
Administrator.
[FR Doc. 2018–05279 Filed 3–14–18; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation of Nominations for
Appointment to the Presidential
Advisory Council on Combating
Antibiotic-Resistant Bacteria
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
The U.S. Department of
Health and Human Services (HHS) is
soliciting nominations of individuals
who are interested in being considered
a voting member for appointment to the
Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria
(Advisory Council). Nominations from
qualified individuals who wish to be
considered for appointment to this
member category of the Advisory
Council are currently being accepted.
DATES: Nominations must be received
no later than 5:00 p.m. ET on April 30,
2018.
ADDRESSES: Information on how to
submit a nomination is on the Advisory
Council website, https://www.hhs.gov/
ash/carb/.
FOR FURTHER INFORMATION CONTACT:
Jomana Musmar, MS, Ph.D., Acting
Designated Federal Officer, Presidential
Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of
the Assistant Secretary for Health, U.S.
Department of Health and Human
Services, Room 715H, Hubert H.
Humphrey Building, 200 Independence
Avenue SW, Washington, DC 20201.
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:34 Mar 14, 2018
Extension
award date
Award recipient name
Jkt 244001
Phone: (202) 690–5566; email: CARB@
hhs.gov. The Advisory Council charter
may be accessed online at https://
www.hhs.gov/ash/carb/. The charter
includes detailed information about the
Advisory Council’s purpose, function,
and structure.
SUPPLEMENTARY INFORMATION: Under
Executive Order 13676, dated
September 18, 2014, authority was given
to the Secretary of HHS to establish the
Advisory Council, in consultation with
the Secretaries of Defense and
Agriculture. Activities of the Advisory
Council are governed by the provisions
of Public Law 92–463, as amended (5
U.S.C. App.), which sets forth standards
for the formation and use of federal
advisory committees. The Advisory
Council will provide advice,
information, and recommendations to
the Secretary of HHS regarding
programs and policies intended to:
preserve the effectiveness of antibiotics
by optimizing their use; advance
research to develop improved methods
for combating antibiotic resistance and
conducting antibiotic stewardship;
strengthen surveillance of antibioticresistant bacterial infections; prevent
the transmission of antibiotic-resistant
bacterial infections; advance the
development of rapid point-of-care and
agricultural diagnostics; further research
on new treatments for bacterial
infections; develop alternatives to
antibiotics for agricultural purposes;
maximize the dissemination of up-todate information on the appropriate and
proper use of antibiotics to the general
public and human and animal
healthcare providers; and improve
international coordination of efforts to
combat antibiotic resistance.
The Advisory Council is authorized to
consist of not more than 30 members,
including the voting and non-voting
members and the Chair and Vice Chair.
The current composition of the
Advisory Council consists of 15 voting
members, including the Chair and Vice
Chair, five non-voting liaison
representative members, and 10 nonvoting ex-officio members.
This announcement is to solicit
nominations to fill seven positions that
are scheduled to be vacated during the
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
02/22/17
02/27/17
03/03/17
05/02/17
05/30/17
Award amount
($)
294,843
743,058
466,752
116,417
538,786
2018 calendar year in the voting
member category. Voting members are
appointed to serve three or four year
terms.
The seven public voting members
sought for this solicitation will be
selected from individuals who are
engaged in: Research on, or
implementation of, interventions
regarding efforts to preserve the
effectiveness of antibiotics by
optimizing their use; advancing research
to develop improved methods for
combating antibiotic resistance and
conducting antibiotic stewardship;
strengthening surveillance of antibioticresistant bacterial infections; preventing
the transmission of antibiotic-resistant
bacterial infections; advancing the
development of rapid point-of-care and
agricultural diagnostics; furthering
research on new treatments for bacterial
infections; developing alternatives to
antibiotics for agricultural purposes;
maximizing the dissemination of up-todate information on the appropriate and
proper use of antibiotics to the general
public and human and animal health
care providers; and improving
international coordination of efforts to
combat antibiotic resistance.
The public voting members will
represent balanced points of view from
human biomedical, public health, and
agricultural fields to include
surveillance of antibiotic-resistant
infections, prevention and/or
interruption of the spread of antibioticresistant threats, or development of
rapid diagnostics and novel treatments.
The public voting members may be
physicians, veterinarians,
epidemiologists, microbiologists, or
other health care professionals (e.g.,
nurses, pharmacists, others); individuals
who have expertise and experience as
consumer or patient advocates
concerned with antibiotic resistance, or
in the fields of agriculture and
pharmaceuticals; and they also may be
from state or local health agencies or
public health organizations. The voting
public members will be appointed by
the Secretary, in consultation with the
Secretaries of Defense and Agriculture.
All public voting members will be
E:\FR\FM\15MRN1.SGM
15MRN1
11544
Federal Register / Vol. 83, No. 51 / Thursday, March 15, 2018 / Notices
classified as special government
employees (SGEs).
Individuals who are appointed to
serve as voting members may be
allowed to receive per diem and
reimbursement for any applicable
expenses for travel that is performed to
attend meetings of the Advisory Council
as authorized by 5 U.S.C. 5703, for
persons employed intermittently in the
Government service. The Advisory
Council meets, at a minimum, two times
per fiscal year depending on the
availability of funds. Meetings are open
to the public, except as determined
otherwise by the Secretary, or other
official to whom the authority has been
delegated, in accordance with
guidelines under the Government in the
Sunshine Act, 5 U.S.C. 552b(c). Every
effort will be made to ensure that the
membership of federal advisory
committees is fairly balanced in terms of
points of view represented. Detailed
information on what is required in a
nomination package and how to submit
one is on the Advisory Council website,
https://www.hhs.gov/ash/carb/.
Dated: March 9, 2018.
Jomana F. Musmar,
Acting Designated Federal Officer,
Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria, Committee
Manager.
[FR Doc. 2018–05278 Filed 3–14–18; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sradovich on DSK3GMQ082PROD with NOTICES
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; Career Development in
Environmental Research.
Time: March 27, 2018.
VerDate Sep<11>2014
17:34 Mar 14, 2018
Jkt 244001
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIEHS/National Institutes of Health,
Keystone Building, 530 Davis Drive, Suite
1002, Research Triangle Park, NC 27709
(Telephone Conference).
Contact Person: Laura A. Thomas,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, National Institute of Environmental
Health Sciences, Research Triangle Park, NC
27709, 919–541–2824, laura.thomas@
nih.gov.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; Environmental Risk Factors
for Breast Cancer.
Date: March 29–30, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Sheraton Imperial Hotel RaleighDurham Airport RP, 4700 Emperor Blvd.,
Durham, NC 27703.
Contact Person: RoseAnne M. McGee,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, National Institute of Environmental
Health Sciences, P.O. Box 12233, MD EC–30,
Research Triangle Park, NC 27709, (919) 541–
0752, mcgee1@niehs.nih.gov.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; Organotypic Culture Models
Developed from Experimental Animals for
Chemical Toxicity Screening.
Date: March 29, 2018.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIEHS/National Institutes of Health,
Keystone, 530 Davis Drive, Research Triangle
Park, NC 27713.
Contact Person: Leroy Worth, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, National Institute of Environmental
Health Sciences, P. O. Box 12233, MD EC–
30/Room 3171, Research Triangle Park, NC
27709 (919) 541–0670, worth@niehs.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: March 9, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–05221 Filed 3–14–18; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel NIAID; Investigator Initiated
Program Project Applications (P01).
Date: April 2, 2018.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Louis A. Rosenthal, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Rm 3G42B, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9834,
Bethesda, MD 20892–9834, (240) 669–5070,
rosenthalla@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Silencing of HIV–1
Proviruses (R61/R33).
Date: April 3, 2018.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Vasundhara Varthakavi,
DVM, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, Room 3E70, National
Institutes of Health, NIAID, 5601 Fishers
Lane, MSC 9823, Bethesda, MD 20892–9823,
(240) 669–5020, varthakaviv@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel NIAID; INVESTIGATOR
INITIATED PROGRAM PROJECT
APPLICATION (P01).
Date: April 11, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
E:\FR\FM\15MRN1.SGM
15MRN1
]]>Agencies
[Federal Register Volume 83, Number 51 (Thursday, March 15, 2018)]
[Notices]
[Pages 11543-11544]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-05278]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation of Nominations for Appointment to the Presidential
Advisory Council on Combating Antibiotic-Resistant Bacteria
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The U.S. Department of Health and Human Services (HHS) is
soliciting nominations of individuals who are interested in being
considered a voting member for appointment to the Presidential Advisory
Council on Combating Antibiotic-Resistant Bacteria (Advisory Council).
Nominations from qualified individuals who wish to be considered for
appointment to this member category of the Advisory Council are
currently being accepted.
DATES: Nominations must be received no later than 5:00 p.m. ET on April
30, 2018.
ADDRESSES: Information on how to submit a nomination is on the Advisory
Council website, https://www.hhs.gov/ash/carb/.
FOR FURTHER INFORMATION CONTACT: Jomana Musmar, MS, Ph.D., Acting
Designated Federal Officer, Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for
Health, U.S. Department of Health and Human Services, Room 715H, Hubert
H. Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201.
Phone: (202) 690-5566; email: [email protected]. The Advisory Council
charter may be accessed online at https://www.hhs.gov/ash/carb/. The
charter includes detailed information about the Advisory Council's
purpose, function, and structure.
SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September
18, 2014, authority was given to the Secretary of HHS to establish the
Advisory Council, in consultation with the Secretaries of Defense and
Agriculture. Activities of the Advisory Council are governed by the
provisions of Public Law 92-463, as amended (5 U.S.C. App.), which sets
forth standards for the formation and use of federal advisory
committees. The Advisory Council will provide advice, information, and
recommendations to the Secretary of HHS regarding programs and policies
intended to: preserve the effectiveness of antibiotics by optimizing
their use; advance research to develop improved methods for combating
antibiotic resistance and conducting antibiotic stewardship; strengthen
surveillance of antibiotic-resistant bacterial infections; prevent the
transmission of antibiotic-resistant bacterial infections; advance the
development of rapid point-of-care and agricultural diagnostics;
further research on new treatments for bacterial infections; develop
alternatives to antibiotics for agricultural purposes; maximize the
dissemination of up-to-date information on the appropriate and proper
use of antibiotics to the general public and human and animal
healthcare providers; and improve international coordination of efforts
to combat antibiotic resistance.
The Advisory Council is authorized to consist of not more than 30
members, including the voting and non-voting members and the Chair and
Vice Chair. The current composition of the Advisory Council consists of
15 voting members, including the Chair and Vice Chair, five non-voting
liaison representative members, and 10 non-voting ex-officio members.
This announcement is to solicit nominations to fill seven positions
that are scheduled to be vacated during the 2018 calendar year in the
voting member category. Voting members are appointed to serve three or
four year terms.
The seven public voting members sought for this solicitation will
be selected from individuals who are engaged in: Research on, or
implementation of, interventions regarding efforts to preserve the
effectiveness of antibiotics by optimizing their use; advancing
research to develop improved methods for combating antibiotic
resistance and conducting antibiotic stewardship; strengthening
surveillance of antibiotic-resistant bacterial infections; preventing
the transmission of antibiotic-resistant bacterial infections;
advancing the development of rapid point-of-care and agricultural
diagnostics; furthering research on new treatments for bacterial
infections; developing alternatives to antibiotics for agricultural
purposes; maximizing the dissemination of up-to-date information on the
appropriate and proper use of antibiotics to the general public and
human and animal health care providers; and improving international
coordination of efforts to combat antibiotic resistance.
The public voting members will represent balanced points of view
from human biomedical, public health, and agricultural fields to
include surveillance of antibiotic-resistant infections, prevention
and/or interruption of the spread of antibiotic-resistant threats, or
development of rapid diagnostics and novel treatments. The public
voting members may be physicians, veterinarians, epidemiologists,
microbiologists, or other health care professionals (e.g., nurses,
pharmacists, others); individuals who have expertise and experience as
consumer or patient advocates concerned with antibiotic resistance, or
in the fields of agriculture and pharmaceuticals; and they also may be
from state or local health agencies or public health organizations. The
voting public members will be appointed by the Secretary, in
consultation with the Secretaries of Defense and Agriculture. All
public voting members will be
[[Page 11544]]
classified as special government employees (SGEs).
Individuals who are appointed to serve as voting members may be
allowed to receive per diem and reimbursement for any applicable
expenses for travel that is performed to attend meetings of the
Advisory Council as authorized by 5 U.S.C. 5703, for persons employed
intermittently in the Government service. The Advisory Council meets,
at a minimum, two times per fiscal year depending on the availability
of funds. Meetings are open to the public, except as determined
otherwise by the Secretary, or other official to whom the authority has
been delegated, in accordance with guidelines under the Government in
the Sunshine Act, 5 U.S.C. 552b(c). Every effort will be made to ensure
that the membership of federal advisory committees is fairly balanced
in terms of points of view represented. Detailed information on what is
required in a nomination package and how to submit one is on the
Advisory Council website, https://www.hhs.gov/ash/carb/.
Dated: March 9, 2018.
Jomana F. Musmar,
Acting Designated Federal Officer, Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria, Committee Manager.
[FR Doc. 2018-05278 Filed 3-14-18; 8:45 am]
BILLING CODE 4150-28-P
